Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Research Grants (R03)
Project #
5R03CA063245-02
Application #
2104980
Study Section
Special Emphasis Panel (SRC (36))
Project Start
1994-02-01
Project End
1997-01-31
Budget Start
1995-02-01
Budget End
1997-01-31
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Northern California Cancer Center
Department
Type
DUNS #
City
Fremont
State
CA
Country
United States
Zip Code
94538
Glaser, S L; Clarke, C A; Chang, E T et al. (2014) Hodgkin lymphoma incidence in California Hispanics: influence of nativity and tumor Epstein-Barr virus. Cancer Causes Control 25:709-25
Glaser, Sally L; Gulley, Margaret L; Clarke, Christina A et al. (2008) Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations. Int J Cancer 123:1499-507
Keegan, Theresa H M; Glaser, Sally L; Clarke, Christina A et al. (2006) Body size, physical activity, and risk of Hodgkin's lymphoma in women. Cancer Epidemiol Biomarkers Prev 15:1095-101
Keegan, Theresa H M; Glaser, Sally L; Clarke, Christina A et al. (2005) Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study. J Clin Oncol 23:7604-13
Glaser, Sally L; Keegan, Theresa H M; Clarke, Christina A et al. (2005) Exposure to childhood infections and risk of Epstein-Barr virus--defined Hodgkin's lymphoma in women. Int J Cancer 115:599-605
Glaser, Sally L; Keegan, Theresa H M; Clarke, Christina A et al. (2004) Smoking and Hodgkin lymphoma risk in women United States. Cancer Causes Control 15:387-97
Glaser, Sally L; Clarke, Christina A; Gulley, Margaret L et al. (2003) Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998. Cancer 98:300-9
Clarke, C A; Glaser, S L; Dorfman, R F et al. (2001) Epstein-Barr virus and survival after Hodgkin disease in a population-based series of women. Cancer 91:1579-87
Glaser, S L; Ambinder, R F; DiGiuseppe, J A et al. (1998) Absence of Epstein-Barr virus EBER-1 transcripts in an epidemiologically diverse group of breast cancers. Int J Cancer 75:555-8